Humoral response to viral vector COVID-19 vaccine in hemodialysis patients
Background The coronavirus disease 2019 (COVID-19) vaccine is not readily available in many countries where dosing interval is spaced more than ideal. Patients with chronic kidney disease, especially those on maintenance hemodialysis, have a tendency for a reduced immune response. This study was und...
Main Authors: | Niranjan Raja, Arul Rajagopalan, Jegan Arunachalam, Arun Prasath, Rakesh Durai, Manorajan Rajendran |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Society of Nephrology
2022-05-01
|
Series: | Kidney Research and Clinical Practice |
Subjects: | |
Online Access: | http://www.krcp-ksn.org/upload/pdf/j-krcp-21-184.pdf |
Similar Items
-
Uremic Optic Neuropathy: A Potentially Reversible Complication of Chronic Kidney Disease
by: Niranjan Raja, et al.
Published: (2022-03-01) -
Clinical Characteristics and Short-Term Outcomes of ESKD Patients Undergoing Hemodialysis with COVID-19 Infection in Madurai, South India
by: Benoy Varghese, et al.
Published: (2022-01-01) -
Clinical Course and Outcome of COVID-19 in Kidney Transplant Recipients: A Single-centre Retrospective Observational Study
by: Shiva Kumar Ammayappan, et al.
Published: (2022-05-01) -
Subjective Assessment of Sleep Quality and Excessive Daytime Sleepiness in Conventional Hemodialysis Population: A Single-Center Experience
by: Velu S, et al.
Published: (2022-03-01) -
Comparing Humoral and Cellular Adaptive Immunity during Convalescent Phase of COVID-19 in Hemodialysis Patients and Kidney Transplant Recipients
by: Dorota Kamińska, et al.
Published: (2021-10-01)